• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine comments

2

Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairman

3

Anthropic billionaire cofounder Jack Clark studied literature, not code—and says liberal arts degrees will win in the AI age

1

Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine comments

2

Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairman

3

Anthropic billionaire cofounder Jack Clark studied literature, not code—and says liberal arts degrees will win in the AI age
Coronavirus

Vladimir Putin says his daughter has received Russia’s first approved COVID-19 vaccine

By
Jake Rudnitsky
Jake Rudnitsky
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Jake Rudnitsky
Jake Rudnitsky
and
Bloomberg
Bloomberg
Down Arrow Button Icon
August 11, 2020, 6:10 AM ET
Google source logo
Add Fortune on Google for similar content.

President Vladimir Putin said Russia has registered its first COVID-19 vaccine, calling it an effective protection against the deadly pathogen, and disclosed that one of his own daughters had already received it.

“As far as I know, this morning the first vaccine against the novel conoravirus infection in the world was registered this morning,” Putin said Tuesday at a televised government meeting.

The announcement represents a propaganda coup for the Kremlin amid a global race to develop vaccines against the coronavirus pandemic that has killed nearly 750,000 people, infected more than 20 million and crippled national economies. Companies including AstraZeneca Plc and Moderna Inc. are still conducting final-stage trials of their vaccines in studies that are expected to soon yield results. Some pharmaceutical companies have called Russia’s rushed registration dangerous.

The vaccine, which is being developed by Moscow’s Gamaleya Institute and the Russian Direct Investment Fund, began Phase 3 trials last week. Medics could begin receiving the vaccine by the end of the month, Deputy Prime Minister Tatyana Golikova said at the meeting.

The news comes as daily COVID-19 cases in Russia dipped below 5,000 for the first time since April 23 as the number continues a slow decline from its May peak. The seven-day moving average has fallen for the last 31 days, with new cases less than half of the 11,656 reported on May 11.

The number of new cases has fallen across Russia after a nationwide lockdown that ended in mid-May. Life has returned to pre-pandemic levels of activity, according to a self-isolation index based on location data gathered by internet company Yandex.

Russia has nearly 900,000 people diagnosed with COVID-19, the fourth-most confirmed cases in the world. It had over 27,000 coronavirus-related deaths in the second quarter, according to Federal Statistics Service data published this week.

About the Authors
By Jake Rudnitsky
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon

Latest in International


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in International


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.